🇮🇳 Lupin Ltd

Press Release 12-11-2026 11:38:42 IST

Overview: Commercial partner Sandoz has launched Ranluspec, Lupin’s biosimilar Ranibizumab, across Europe excluding Germany following European Commission approval.

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest